glp 1 mounjaro for weight loss GLP-1 Treatments: Ozempic, Mounjaro, and Other Options| PMN Weighing in on GLP-1 Weight

Limited Scope of FDA Approval The most significant limitation is the narrow approved indication: FDA approval restricted exclusively to acquired, generalized hypoactive sexual desire disorder in premenopausal women No approved indication for men despite Phase 2 evidence of erectile dysfunction improvement No approval for postmenopausal women No approval for other forms of sexual dysfunction beyond HSDD All use outside this single indication represents off-label prescribing based on limited clinical trial data and physician clinical experience

K.DorresteinP

Evidence of oxidative stress in AA patients 2.1

Four proline residues, including an unusual triple-proline sequence, confer resistance to enzymatic degradation